SHREE GANESH REMEDIES
Back to Cashflow Statement
|
SHREE GANESH REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.09 Cr | ₹9.84 Cr | ₹-0.48 Cr | ₹-0.18 Cr |
What is the latest Cash Flow from Financing Activities ratio of SHREE GANESH REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.09 Cr |
| Mar2024 | ₹9.84 Cr |
| Mar2020 | ₹-0.48 Cr |
| Mar2019 | ₹-0.18 Cr |
How is Cash Flow from Financing Activities of SHREE GANESH REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.09 Cr | Negative | |
| Mar2024 | ₹9.84 Cr | Positive | |
| Mar2020 | ₹-0.48 Cr | Negative | |
| Mar2019 | ₹-0.18 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹831.2 Cr | 4.4% | 27.1% | 5.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,096.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,807.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,718.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,971.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,752.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 4.4% |
27.1% |
5.3% |
| SENSEX | -0.5% |
-3.3% |
-7.6% |
You may also like the below Video Courses